Catalyst Wire Dossier Catalyst Wire Dossier

atorvastatin + perindopril fixed-dose combination S05167

· Institut de Recherches Internationales Servier
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for atorvastatin + perindopril fixed-dose combination S05167, covering 2023-10-18 to 2023-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia [Phase 3]

See pricing